Search Results 351-360 of 974 for ���������������������������������������������:PC90���

  1. Medical Research & Education - Mayo Clinic News Network

    At the first U.S. 'Undiagnosed Hackathon,' scientists from around the world will team up at Mayo Clinic to solve unsolved medical mysteries.

  2. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...

  3. Paget's disease of bone - Doctors and departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

  4. A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

    The purpose of this dose escalation study is to evaluate the safety profile of escalating doses and dose schedules of NXP900. Participation eligibility.

  5. A Study to Evaluate the Effectiveness and Safety of PCS499 in Treating Ulcerations in Patients who have Necrobiosis Lipoidica - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness of PCS499 at 6 Months in treating ulcerations in patients who have necrobiosis lipoidica.

  6. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have developed a genetic test that can help predict how people will respond to weight loss medications such as GLP-1s. Latest stories.

  7. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most[...] ...

  8. Sept. 24, 2013 Ginger Plumbo 507-284-5005 (days) 507-284-2511 (evenings) Email: newsbureau@mayo.edu EMBARGOED: Hold for release

    NEW YORK — During the Healthier Futures plenary at the Clinton Global Initiative (CGI) Annual. Meeting, Chelsea Clinton was joined onstage by Pro Mujer's ...

  9. Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

    The drug used for HIPEC will be carboplatin, a Food and Drug Administration (FDA) approved drug for use in ovarian, fallopian tube or primary peritoneal cancer.

  10. Medical Research & Education - Mayo Clinic News Network

    ROCHESTER, Minn. — A Mayo Clinic study finds that a shortened, less intense course of radiation and chemotherapy after minimally invasive surgery for ...